Evaluation of Rifalazil in a Combination Treatment Regimen as an Alternative to Isoniazid-Rifampin Therapy in a Mouse Tuberculosis Model
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.44.11.3167-3168.2000
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2000
Authors
Publisher
American Society for Microbiology